Kafetzis D A, Astra H, Mitropoulos L
Second Department of Paediatries, P & A Kyriakou Children's Hospital, University of Athens, Athens 11527, Greece.
Eur J Clin Microbiol Infect Dis. 1997 Apr;16(4):283-6. doi: 10.1007/BF01695632.
A randomized comparative clinical trial was conducted to investigate the possibility of decreasing the duration of treatment of acute otitis media by comparing the clinical outcome and safety of a five-day and a ten-day course of cefprozil. A total of 708 pediatric patients were enrolled in the study, 560 of whom were evaluable for efficacy. Cefprozil was found to be completely effective in 87.1% of cases after five days of treatment, and in 91.2% after ten days of treatment. Of 19 patients with three or more previous episodes of acute otitis media, ten patients in the ten-day treatment group had a 100% cure rate, while in the five-day group four experienced cure, three improvement, and two failure. A five-day course of treatment with cefprozil can be recommended only if children have no history of recurrent acute otitis media.
进行了一项随机对照临床试验,通过比较头孢丙烯五日疗程和十日疗程的临床疗效及安全性,研究缩短急性中耳炎治疗疗程的可能性。共有708名儿科患者参与该研究,其中560名可评估疗效。治疗五天后,头孢丙烯在87.1%的病例中完全有效,治疗十天后这一比例为91.2%。在19名既往有三次或更多次急性中耳炎发作史的患者中,十日治疗组的10名患者治愈率达100%,而五日治疗组中,4名患者治愈,3名改善,2名治疗失败。仅当儿童无复发性急性中耳炎病史时,才推荐使用头孢丙烯进行五日疗程的治疗。